What was Galapagos’s price range in the past 12 months?
Galapagos lowest share price was €26.90 and its highest was €41.88 in the past 12 months.
What is Galapagos’s market cap?
Currently, no data Available
When is Galapagos’s upcoming earnings report date?
Galapagos’s upcoming earnings report date is May 02, 2024 which is in 13 days.
How were Galapagos’s earnings last quarter?
Galapagos released its earnings results on Feb 22, 2024. The company reported €2.39 earnings per share for the quarter, beating the consensus estimate of -€1.975 by €4.365.
What happened to Galapagos’s price movement after its last earnings report?
Galapagos reported an EPS of €2.39 in its last earnings report, beating expectations of -€1.975. Following the earnings report the stock price went down -4.879%.
Which hedge fund is a major shareholder of Galapagos?
Currently, no hedge funds are holding shares in GB:0JXZ
Galapagos NV is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company's product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.